Privia Health Group, Inc. (NASDAQ:PRVA) Stock Holdings Increased by Marshall Wace LLP

Marshall Wace LLP lifted its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 111.8% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 338,259 shares of the company's stock after buying an additional 178,548 shares during the period. Marshall Wace LLP owned 0.28% of Privia Health Group worth $6,613,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Rhumbline Advisers boosted its holdings in shares of Privia Health Group by 1.3% during the fourth quarter. Rhumbline Advisers now owns 287,200 shares of the company's stock worth $5,615,000 after purchasing an additional 3,658 shares during the last quarter. Nordea Investment Management AB boosted its stake in Privia Health Group by 33.1% in the 4th quarter. Nordea Investment Management AB now owns 349,773 shares of the company's stock worth $6,953,000 after buying an additional 86,910 shares during the last quarter. Franklin Resources Inc. grew its holdings in Privia Health Group by 2.2% in the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock valued at $23,092,000 after buying an additional 28,480 shares during the period. Barclays PLC increased its stake in shares of Privia Health Group by 240.3% during the 3rd quarter. Barclays PLC now owns 224,018 shares of the company's stock valued at $4,079,000 after acquiring an additional 158,188 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Privia Health Group by 8.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company's stock worth $3,430,000 after acquiring an additional 14,641 shares during the period. Institutional investors and hedge funds own 94.48% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Piper Sandler boosted their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a report on Friday, February 28th. Barclays boosted their price objective on shares of Privia Health Group from $21.00 to $23.00 and gave the company an "equal weight" rating in a research note on Thursday, April 10th. JMP Securities set a $29.00 price objective on Privia Health Group in a report on Friday, February 28th. Truist Financial lifted their target price on Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a report on Thursday, April 10th. Finally, Canaccord Genuity Group upped their price target on Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. One analyst has rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, Privia Health Group presently has an average rating of "Buy" and an average target price of $27.14.

Insider Activity at Privia Health Group

In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the firm's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the transaction, the chief financial officer now directly owns 179,676 shares of the company's stock, valued at $4,021,148.88. This trade represents a 3.04 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 10.70% of the stock is currently owned by company insiders.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA traded down $0.29 during mid-day trading on Friday, hitting $23.17. 383,161 shares of the company traded hands, compared to its average volume of 775,827. The firm has a market cap of $2.81 billion, a P/E ratio of 231.72, a PEG ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $26.04. The firm's 50 day simple moving average is $23.64 and its 200 day simple moving average is $21.90.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.